The British Thoracic Oncology Group (BTOG) conference took place in Dublin this month, with a number of studies coordinated by the CR UK & UCL CTC involved.
The
SUMMIT study had 4 poster presentations. These exhibited early data in the management of pulmonary nodules, extrapulmonary incidental findings and pulmonary findings, as well as data highlighting the invitation strategy of this important lung cancer CT screening study.
The
EARL study, examining electrocautery ablation for the prevention of lung cancer, had a poster presentation and also an oral presentation in which Dr Lukas Kalinke presented the trial endpoints, inclusion criteria, recruitment strategy, and details on the investigational electrocautery treatment (see photo).
The
SARON study, looking at stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer, had a poster presentation highlighting the recent changes in trial design to allow patients who would usually receive immunotherapy to take part in the trial. Dr Fiona McDonald relaunched the trial at BTOG and presented the changes to investigators in attendance.
We would also like to congratulate Dr Sophie Tisi, who was the runner up at the conference’s best poster presentation category for her SUMMIT study poster.
Image: Dr Lukas Kalinke presents EARL at the BTOG conference